Financial Times· 21.10.2026, 04:00en
The $15bn ‘viral’ AI start-up changing how American doctors treat patients
Founder of OpenEvidence chatbot says two-thirds of US physicians use the ad-powered tool, prompting a debate about patient care
- Autor
- redaktionell nicht genannt
- Einordnung
- keine Bewertung